Synthesis and characterization of thienorphine and its glucuronide conjugate

Synthetic Communications

Volumn 35, Issue 5, 2005, Pages 701-710

  Liu, Chun He ^a   Liu, He ^a   Han, Xiang Yu ^a   Wu, Bo ^a   Zhong, Bo Hua ^a   Gong, Ze Hui ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

Author keywords

Glucuronide conjugate; Thienorphine; X ray analysis

Indexed keywords

2 (THIOPHEN 2 YL)ETHYLMAGNESIUM BROMIDE; 7ALPHA ACETYL 6,14 ENDOETHENOTETRAHYDROTHEBAINE; BROMINE DERIVATIVE; GLUCURONIDE; N CYCLOPROPYLMETHYL 7ALPHA [1 HYDROXY 1 METHYL 3 (THIEN 2 YL)PROPYL] 6,14 ENDOETHANOTETRAHYDRONORORIPAVINE; OPIATE RECEPTOR; ORIPAVINE; THEBAINE; THIENORPHINE; THIENORPHINE 3 GLUCURONIDE; UNCLASSIFIED DRUG;

ALKYLATION; ARTICLE; DEMETHYLATION; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG GLUCURONIDATION; DRUG METABOLISM; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; GRIGNARD REACTION; STRUCTURE ANALYSIS; X RAY ANALYSIS;

EID: 15244345392     PISSN: 00397911     EISSN: None     Source Type: Journal    
DOI: 10.1081/SCC-200050367     Document Type: Article

References (24)

1. Zinnerman, D. M.; Leander, J. D. Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents. J. Med. Chem. 1990, 33, 895-902.
2. López, D.; Quiñoá, E.; Riguera, R. The [4 + 2] addition of singlet oxygen to thebaine: new access to highly functionalized morphine derivatives via opioid endoperoxides. J. Org. Chem. 2000, 65, 4671-4678.
3. Bourdonnec, S. L.; Kouhen, R. E.; Poda, G.; Law, P. Y.; Loh, H. H.; Ferguson, D. M.; Portoghese, P. S. Covalently induced activation of the δ-opioid receptor by a fluorogenic affinity label, 7′- (phthalaldehydecarboxamido)-naltrindole (PNTI). J. Med. Chem. 2001, 44, 1017-1020.
4. 1 phenotypes. Selective targeting of δ-κ heterodimers. J. Med. Chem. 2004, 47, 2969-2972.
5. Crome, H. B. Treatment interventious-looking towards the millennium. Drug Alcohol Depend. 1999, 55, 247-263.
6. Casy, A. F.; Parfitt, R. T. Opioid Analgesics: Chemistry and Receptors, Plenum Press: New York, 1986.
7. Marton, J.; Simon, C.; Hosztafi, S.; Szabo, Z.; Marki, A.; Borsodi, A.; Makleit, S. New nepenthone and thevinone derivatives. Bioorg. Med. Chem. 1997, 5, 369-382.
8. Husbands, S. M.; Breeden, S. W.; Grivas, K.; Lewis, J. W. Ring constrained analogues of the orivinols: the furanopmorphides. Bioorg. Med. Chem. Lett. 1999, 9, 831-834.
9. 3]-testosterone- epitestosterone and their glucuronides and sulfates. J. Steroid. Biochem. Molec. Biol. 1996, 58, 225-234.
10. Salem, A.; Hope, W. Role of morphine glucuronides metabolites in morphine dependence in the rat. Pharmacol. Biochem. Behavior. 1997, 87, 801-807.
11. Baker, L.; Dye, A.; Ratka, A. Effects of morphine glucuronides on the function of opioid receptors in human SK-N-SH cells. Neurosci. Lett. 2000, 281, 1-4.
12. Salvatella, M.; Arsequell, G.; Valencia, G.; Rodriguez, R. E. A highly toxic morphine-3-glucuronide derivatives. Bioorg. Med. Chem. Lett. 2004, 14, 905-908.
13. Bentley, K. W.; Hardy, D. G.; Meek, B. Novel analgesics and molecular rearrangement in the morphine-thebaine group. II. Alcohols derived from 6.14-endo-etheno- and 6.14-endo-ethanotetrahydrothebaine. J. Am. Chem. Soc. 1967, 89, 3273-3280.
14. Bentley, K. W.; Hardy, D. G. Novel analgesics and molecular rearrangement in the morphine-thebaine group. III. Alcohols of the 6.14-endo-etheno- tetrahydrooripavine series and derived analogs of N-allylnormorphine and -norcodeine. J. Am. Chem. Soc. 1967, 89, 3281-3291.
15. Bentley, K. W.; Hardy, D. G.; Crocker, H. P.; Haddlesey, D. I.; Mayor, P. A. Novel analgesics and molecular rearrangement in the morphine-thebaine group. IV. Base-catalyzed rearrangements in the 6,14-endo-ethenotetrahydrothebaine series. J. Am. Chem. Soc. 1967, 89, 3312-3321.
16. Marton, J.; Szabo, Z.; Garadnay, S.; Mikos, S.; Makleit, S. Studies on the synthesis of β-thevinone derivative. Tetrahedron 1998, 54, 9143-9152.
17. Loew, C. H.; Berkowitz, D. S. Quantiom chemical studies of morphine-like opiate narcotics. Effect of N-substituent variations. J. Med. Chem. 1975, 18, 656-662.
18. Loew, C. H.; Berkowitz, D. S. Intramolecular hydrogen bonding and conformational studies or of bridged thebaine and oripavine opiate narcotic agonists and antagonists. J. Med. Chem. 1979, 22, 603-607.
19. Desiraju, G. R. The C-H⋯O hydrogen bond in crystals: What is it? Acc. Chem. Res. 1991, 24, 290-296.
20. Bollenback, G. N.; Long, J. W.; Benjamin, D. G.; Lindquist, J. A. The synthesis of aryl-D-glucopyranosiduronic acids. J. Am. Chem. Soc. 1955, 77, 3310-3315.
21. Leu, Y. L.; Roffler, S. R.; Chern, J. W. Design and synthesis of water-soluble glucuronide derivatives of camptothecin for cancer prodrug monotherapy and antibody-directed enzyme prodrug therapy (ADEPT). J. Med. Chem. 1999, 42, 3623-3628.
22. Berrang, B.; Twine, C. E.; Hennessee, G. L.; Carroll, F. I. Synthesis of morphine-3 glucuronide. Syn. Commun. 1975, 5, 231-236.
23. Sheldrick, G. M. SHELXS-97, Program for X-ray Crystal Structure Solution, Göttingen University: Germany, 1997; Sheldrick, G. M. SHELXL-97, Program for X-ray Crystal Structure Refinement; Germany, 1997.
24. Sheldrick, G. M. SHELXS-97, Program for X-ray Crystal Structure Solution, Göttingen University: Germany, 1997; Sheldrick, G. M. SHELXL-97, Program for X-ray Crystal Structure Refinement; Germany, 1997.